MicroRNAs Induce Epigenetic Reprogramming and Suppress Malignant Phenotypes of Human Colon Cancer Cells

• Hisataka Ogawa,

  Affiliations Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan, Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  ⨯
• Xin Wu,

  Affiliation Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  ⨯
• Koichi Kawamoto,

  Affiliations Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan, Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  ⨯
• Naohiro Nishida,

  Affiliations Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan, Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  ⨯
• Masamitsu Konno,

  Affiliation Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  ⨯
• Jun Koseki,

  Affiliation Department of Cancer Profiling Discovery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  ⨯
• Hidetoshi Matsui,

  Affiliation Faculty of Mathematics, Kyushu University, Fukuoka, Japan

  ⨯
• Kozou Noguchi,

  Affiliations Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan, Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  ⨯
• Noriko Gotoh,

  Affiliation Division of Cancer Cell Biology, Cancer Research Institute of Kanazawa University, Kakuma-machi, Kanazawa, Japan

  ⨯
• Tsuyoshi Yamamoto,

  Affiliation Department of Bioorganic Chemistry, Osaka University Graduate School of Pharmaceutical Science, Suita, Osaka, Japan

  ⨯
• Kanjiro Miyata,

  Affiliation Department of Materials Engineering, The University of Tokyo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Nobuhiro Nishiyama,

  Affiliations Department of Materials Engineering, The University of Tokyo, Bunkyo-ku, Tokyo, Japan, Tokyo Institute of Technology, Chemical Resources Laboratory, Yokohama, Midori-ku, Japan

  ⨯
• Hiroaki Nagano,

  Affiliation Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  ⨯
• Hirofumi Yamamoto,

  Affiliation Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  ⨯
• Satoshi Obika,

  Affiliation Department of Bioorganic Chemistry, Osaka University Graduate School of Pharmaceutical Science, Suita, Osaka, Japan

  ⨯
• Kazunori Kataoka,

  Affiliation Department of Materials Engineering, The University of Tokyo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Yuichiro Doki,

  Affiliation Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  ⨯
• Masaki Mori ,

  * E-mail: hishii@gesurg.med.osaka-u.ac.jp (HI);mmori@gesurg.med.osaka-u.ac.jp (MM)

  Affiliation Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  ⨯
•  [ ... ],
• Hideshi Ishii

  * E-mail: hishii@gesurg.med.osaka-u.ac.jp (HI);mmori@gesurg.med.osaka-u.ac.jp (MM)

  Affiliations Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Osaka, Japan, Department of Cancer Profiling Discovery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

  ⨯
• [ view all ]
• [ view less ]